Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Strategies for Generating Diverse Antibody Repertoires Using Transgenic Animals Expressing Human Antibodies
Weihsu C. Chen, Christopher M. Murawsky
Frontiers in Immunology (2018) Vol. 9
Open Access | Times Cited: 39

Showing 1-25 of 39 citing articles:

Hybridoma technology a versatile method for isolation of monoclonal antibodies, its applicability across species, limitations, advancement and future perspectives
Hilal Ahmed Parray, Shivangi Shukla, Sweety Samal, et al.
International Immunopharmacology (2020) Vol. 85, pp. 106639-106639
Open Access | Times Cited: 165
Single B cell technologies for monoclonal antibody discovery
Alessandro Pedrioli, Annette Oxenius
Trends in Immunology (2021) Vol. 42, Iss. 12, pp. 1143-1158
Open Access | Times Cited: 122
The Dawn of a New Era: Targeting the “Undruggables” with Antibody-Based Therapeutics
Linghui Qian, Xuefen Lin, Xue Gao, et al.
Chemical Reviews (2023) Vol. 123, Iss. 12, pp. 7782-7853
Closed Access | Times Cited: 61
Challenges and opportunities for antiviral monoclonal antibodies as COVID-19 therapy
Carlos Cruz‐Teran, Karthik Tiruthani, Morgan D. McSweeney, et al.
Advanced Drug Delivery Reviews (2020) Vol. 169, pp. 100-117
Open Access | Times Cited: 78
An antibody from single human V H -rearranging mouse neutralizes all SARS-CoV-2 variants through BA.5 by inhibiting membrane fusion
Sai Luo, Jun Zhang, Alex J.B. Kreutzberger, et al.
Science Immunology (2022) Vol. 7, Iss. 76
Open Access | Times Cited: 44
CD19 CAR antigen engagement mechanisms and affinity tuning
Changhao He, Jorge Mansilla‐Soto, Nandish Khanra, et al.
Science Immunology (2023) Vol. 8, Iss. 81
Open Access | Times Cited: 31
Targeted Therapies: The Role of Monoclonal Antibodies in Disease Management
Akram N. Salah, Amr H. Hashem, Mohamed Bakr Zaki, et al.
Journal of Biochemical and Molecular Toxicology (2025) Vol. 39, Iss. 2
Closed Access
Innovative Immunization Strategies for Antivenom Development
Erick Bermúdez-Méndez, Albert Fuglsang-Madsen, Sofie Føns, et al.
Toxins (2018) Vol. 10, Iss. 11, pp. 452-452
Open Access | Times Cited: 71
Antibody glycosylation: impact on antibody drug characteristics and quality control
Ziyan Wang, Jianwei Zhu, Huili Lu
Applied Microbiology and Biotechnology (2020) Vol. 104, Iss. 5, pp. 1905-1914
Closed Access | Times Cited: 49
Co-immunization with hemagglutinin stem immunogens elicits cross-group neutralizing antibodies and broad protection against influenza A viruses
Syed M. Moin, Jeffrey C. Boyington, Seyhan Boyoglu-Barnum, et al.
Immunity (2022) Vol. 55, Iss. 12, pp. 2405-2418.e7
Open Access | Times Cited: 28
Assay format diversity in pre-clinical immunogenicity risk assessment: Toward a possible harmonization of antigenicity assays
Axel Ducret, Chloé Ackaert, Juliana Bessa, et al.
mAbs (2021) Vol. 14, Iss. 1
Open Access | Times Cited: 36
Uses and Challenges of Antiviral Polyclonal and Monoclonal Antibody Therapies
Evi Struble, Jonathan Rawson, Tzanko S. Stantchev, et al.
Pharmaceutics (2023) Vol. 15, Iss. 5, pp. 1538-1538
Open Access | Times Cited: 12
Next-Generation Therapeutic Antibodies for Cancer Treatment: Advancements, Applications, and Challenges
A. Raja, Abhishek Kasana, Vaishali Verma
Molecular Biotechnology (2024)
Closed Access | Times Cited: 3
High-Throughput Monoclonal Antibody Discovery from Phage Libraries: Challenging the Current Preclinical Pipeline to Keep the Pace with the Increasing mAb Demand
Nicola Zambrano, Guendalina Froechlich, Dejan Lazarevič, et al.
Cancers (2022) Vol. 14, Iss. 5, pp. 1325-1325
Open Access | Times Cited: 20
Real-World Lab Data in Natalizumab Treated Multiple Sclerosis Patients Up to 6 Years Long-Term Follow Up
Maxi Kaufmann, Rocco Haase, Undine Proschmann, et al.
Frontiers in Neurology (2018) Vol. 9
Open Access | Times Cited: 37
High throughput identification of human monoclonal antibodies and heavy-chain-only antibodies to treat snakebite
Julien Slagboom, A. Lewis, Wietse M. Schouten, et al.
Toxicon X (2024) Vol. 21, pp. 100185-100185
Open Access | Times Cited: 2
Diverse human VH antibody fragments with bio-therapeutic properties from the Crescendo Mouse
Yumin Teng, Joyce L. Young, Bryan Edwards, et al.
New Biotechnology (2019) Vol. 55, pp. 65-76
Open Access | Times Cited: 28
Retrospective analysis of the preparation and application of immunotherapy in cancer treatment (Review)
Jiachen Lu, Jianing Ding, Zhaoxia Liu, et al.
International Journal of Oncology (2022) Vol. 60, Iss. 2
Open Access | Times Cited: 12
A mammalian cell display platform based on scFab transposition
Chang Jing, Christoph Rader, Haiyong Peng
Antibody Therapeutics (2023) Vol. 6, Iss. 3, pp. 157-169
Open Access | Times Cited: 5
Antibody engineering and its therapeutic applications
Divya Kandari, Rakesh Bhatnagar
International Reviews of Immunology (2021) Vol. 42, Iss. 2, pp. 156-183
Closed Access | Times Cited: 13
Miniaturized single-cell technologies for monoclonal antibody discovery
Julie Van Lent, Jolien Breukers, Karen Ven, et al.
Lab on a Chip (2021) Vol. 21, Iss. 19, pp. 3627-3654
Open Access | Times Cited: 13
Leveraging monoclonal antibodies as therapeutics to address antimicrobial resistance in bacteria
Vaishali Verma
Journal of Applied Biology & Biotechnology (2022)
Open Access | Times Cited: 6
Rabbits transgenic for human IgG genes recapitulating rabbit B-cell biology to generate human antibodies of high specificity and affinity
Francesca Ros, Sonja Offner, Stefan Klostermann, et al.
mAbs (2020) Vol. 12, Iss. 1
Open Access | Times Cited: 8
High-efficacy, high-manufacturability human VH domain antibody therapeutics from transgenic sources
Kasandra Bélanger, Jamshid Tanha
Protein Engineering Design and Selection (2021) Vol. 34
Open Access | Times Cited: 7
Phage Display Technology: A Way Forward for Production of Recombinant Monoclonal Antibodies
Ajay Patel, Manisha Parmar, Payal Patel, et al.
(2024), pp. 1-27
Closed Access
Page 1 - Next Page

Scroll to top